RVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

Magnesium supplements are said to help with a long list of ailments: sleep problems, migraine headaches, depression, high ...

Forward-looking statements also include statements regarding the expected benefits of the transactions contemplated ... and completion of preclinical studies and clinical trials; (xv) risks related to ...

While exercise is generally beneficial for a person's overall health, physical activities may increase the risk of adverse cardiovascular ... support device performance or clinical, or safety outcomes ...

To describe the destructive effects of intense health anxiety to his young doctors ... patients were more frustrating to care ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...

SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today ...

Sagimet Biosciences (SGMT) announced the presentation of Phase 2b data demonstrating the anti-fibrotic activity of its fatty acid synthase ...